To study the variability of the fraction of CPK released from the infarcted heart which enters the serum (serum entry ratio, or SER) with size and model of infarction, nine dogs underwent homogeneous infarctions (LAD ligation) of varying sizes, and 10 dogs underwent scattered infarctions (left coronary embolization). In homogeneous infarcts there was an inverse linear relationship of SER to infarct size (IS) (SER = -0.8514% LV + 0.345, r = 0.98). No such relationship was found for scattered infarcts. CPK Kd (exponential disappearance constant for CPK) was not significantly different in homogeneous (-0.00178 min-') vs scattered infarcts (-0.00195 min-m). Although similar IS was produced in each (homogeneous 19.9% LV, scattered 18.4% LV) cumulative CPK serum entry (CPKr) was much lower in homogeneous (4175 mIU/ml) vs scattered infarcts (7,296 mIU/ml). SER was also much lower in homogeneous (17.7%) vs scattered infarcts (29.0%) (P < 0.025). Cumulative CPK plateau occurred significantly later in homogeneous (15.8 hours) vs scattered infarcts (11.7 hours) (P< 0.01).
THE SERIAL CPK TECHNIQUE was developed by Sobel and Shell for the noninvasive estimation of myocardial infarction size.1 2 The disappearance of CPK from the serum is monoexponential,l 3 and it is therefore possible to determine total serum entry of CPK from serial serum samples and from knowledge of the distribution volume. Actual infarct size in grams of myocardium is then determined from knowledge of the normal myocardial CPK content, the fractional depletion of CPK from homogeneously infarcted myocardium, and the fraction of CPK depleted from the heart which actually enters the serum (serum entry ratio, or SER). The work of Sobel and Shell in dogs revealed an SER of 15%, a figure which has been widely used in dog studies and which has been extrapolated for use in humans. 2 We reasoned that the small proportion of CPK depleted from the heart which eventually enters the serum might be a source of large errors in calculation of infarct sizea 3% change in local destruction of CPK would produce a 20% change in serum entry of CPK. Roe and coworkers have previously noted relatively less total enzyme release in larger as compared to smaller infarcts. 4 They speculated that small regions of infarction might release CPK in amounts equivalent to large zones of infarction because of better collateral perfusion in the smaller zones. They noted the wide variability of SER from one dog to another in the original work of Shell.5 The escape of CPK from a zone of infarction depends in part on the access of the CPK to perfused myocardium. We postulated that the larger a zone of infarction, the slower would be the escape of CPK from its center, allowing more time for local destruction. We further postulated that the model of infarction might influence the SER. The CPK from multiple scattered small infarcts should have greater access to the circulation than that from zones of homogeneously infarcted myocardium. We studied the relationship of SER to the size of homogeneous infarcts, and the variability of SER in homogeneous vs scattered infarcts.
Methods Ligation Dogs (Homogeneous Infarct Model)
Mongrel dogs weighing [22] [23] [24] [25] [26] [27] kg (mean 24 kg) were anesthetized with sodium pentobarbital 30 mg/kg I.V. intubated, and anesthesia was maintained with a mixture of N20, 02 and 0.5% flurothane, using a modified Boyle K anesthetic machine. The heart was exposed through a left thoracotomy and a silk snare was placed about the left anterior descending coronary artery (LAD) at some point between the first and fourth diagonal branches, depending on the size of infarct desired. The chest was closed and the snare enclosed in a subcutaneous pouch. Preoperative penicillin and dihydrostreptomycin, and postoperative (four days) ampicillin were administered I.V. A heparin-filled external jugular vein catheter was placed and the dog was allowed to recover. Serum CPK samples were obtained every 4-6 hours for 48 hours, and then twice daily for five to seven days. At this point, the dog was again anesthetized with pentobarbital 30 mg/kg, the snare was pulled tightly and secured, and the dog was allowed to regain consciousness. Three-milliliter blood samples were obtained from the jugular catheter qlhr X 36 hr, and q4hr for 12 more hours. Plasma volume was maintained with equal aliquots of physiological saline. Serum was removed and frozen at 20°C. At 48 hours postligation, the dog was sacrificed (pentobarbital plus 20% KCI I.V.) and the heart was quickly removed.
Embolization Dogs (Scattered Infarct Model) Mongrel dogs weighing [21] [22] [23] [24] [25] [26] [27] [28] [29] kg (mean 24.8 kg) were anesthetized with pentobarbital 30 mg/kg and intubated. A heparin-filled external jugular vein catheter was placed in each dog. A small incision was made over the right femoral artery and a preshaped 7-F polyurethane catheter was introduced over a guidewire into the femoral artery. The catheter was advanced to the left coronary artery and a small hand injection of Renografin 76 (meglumine diatrizoate) (2-3 ml) was used to demonstrate selective catheterization of the left coronary artery with visualization of the LAD and circumflex vessels. An injection of 300 ,u carbonized plastic microspheres (1-2 mg/kg body weight) suspended in 15-20% dextran (0.5 ml) was then made and flushed in with physiological saline (1 ml, four or five times). A repeat injection of Renografin 76 (2-3 ml) was made to ensure that selective catheterization of the left coronary artery without significant washout had been maintained. Control experiments using peripheral injection of microspheres ensured that release of CPK from noncardiac tissues as a result of escape of microspheres would not contribute significantly to total CPK entry to serum. The catheter was removed, the femoral artery was repaired, and the dog was allowed to recover. Serial blood samples were obtained as above to 48 hours, when the dog was sacrificed and the heart removed.
Tissue
The heart was immediately placed on aluminum foil in an ice-filled container. The ventricles were separated from the atria and opened. The visual distribution and size of infarction was noted. All possible fat and connective tissue was removed, and 300-500 mg biopsies were cut from areas of uninfarcted left ventricle and right ventricle. Thirty to 60 mg biopsies were taken from the central zones of densely infarcted myocardium. Atrial biopsies were also taken. The left ventricle and right ventricle were then separately cut into several large pieces of 20-40 g and weighed. All tissue was frozen at -20°C. On a subsequent day, the muscle was thawed, and each piece was minced with scissors and placed in 4 volumes of ice-cold KCI 10 mM/1 with 2 mercaptoethanol 1 mM/1.6 The tissue was homogenized using two 30-second bursts at maximum speed setting on a VirTis 23 homogenizer. Optimal dilutions, time, and speed settings were determined from multiple preliminary investigations. The homogenate was centrifuged at 2,000 g for 20 minutes and the CPK content of the supernate was deter-mined using the SKI bulk reagent modification of the Rosalki method7 at 37°C. It was thus possible to calculate for each dog preinfarction CPK content of the left ventricle and right ventricle using the uninfarcted myocardial biopsies and the ventricular weights. Total residual CPK content of the left ventricle and right ventricle was determined from the homogenization of the entire ventricles, and total myocardial CPK depletion was calculated from the difference. A mean value for residual CPK content at the center of homogeneously infarcted myocardium was obtained in each of the nine ligation dogs. This value was related to the total CPK depletion in each dog to permit expression of total infarct size quantitatively in grams of homogeneously infarcted myocardium. In embolization dogs the total CPK depletion was determined as above, but CPK depletion from the centers of infarcted zones was assumed equal to the mean obtained from ligation dogs, to circumvent the impossibility of obtaining a biopsy of completely infarcted tissue in the setting of scattered small infarcts.
Serum Samples
Serum samples were kept frozen at -20°C until the completion of sampling when they were thawed and CPK concentrations were determined in duplicate as a batch for each dog. Control CPK concentration was subtracted from each value, which was then plotted on a log y-axis against time on the x-axis. The curve of CPK values was visually inspected and once the steep and linear downslope began, all subsequent points were used to determine Kd and r2 (where Kd = exponential disappearance constant for CPK and r2 = correlation coefficient) from the least squares approximation technique. A computer program was used to determine points on the curve of cumulative serum entry of CPK. Cumulative entry of CPK per milliliter of serum was determined from the plateau of the cumulative CPK curve, and an assumed plasma volume (PV) of 0.05 X body weight2' 3, 8 was used to determine total serum entry of CPK. 
Results
The homogeneous infarction study included nine dogs who underwent ligation of the LAD. The scattered infarction study included 10 dogs who had embolization of the left coronary artery. Myocardial necrosis was well circumscribed in the area perfused by the occluded artery in the ligation dogs and generally was transmural at the apex, with subendocardial extension proximally ( fig. IA ). In the embolization dogs necrosis was randomly scattered throughout the left ventricle ( fig. 1B ) and could be present in the myocardium at any level from endocardium to epicardium. Necrosis was confined to the left ventricle in ligation dogs, but there was significant right ventricular infarction present in the embolization dogs. Comparisons were made in terms of the degree of left ventricular infarction found, and in embolization dogs plateau CPK values were corrected to determine what serum CPK could be attributed to left ventricular necrosis.
Myocardial CPK Content CPK content of normal left ventricular myocardium (ligation dogs) was 1865 IU/g ± 148 (mean ± SD) (table IA) . This value did not differ significantly from that for normal right ventricular myocardium, which was 1748 IU/g ± 214. The CPK content of atrial myocardium (990 IU/g + 358) was markedly less than that of left ventricular myocardium (P < 0.001).
CPK depletion at the center of homogeneously infarcted myocardium was 81.5% + 11.8 (mean ± SD) for ligation dogs (table IA) . The identification of a homogeneously infarcted zone large enough to biopsy in embolization dogs was difficult, and the CPK depletions observed (66.7% : 13.7) (table iB) probably represented assay of a mixture of infarcted and normal tissue.
Serum Entry Ratio
An eight-fold range of infarct size expressed as percent of left ventricle infarcted was produced in the ligation dogs (4.62 -34.9% of left ventricle) (table   IA) . This range was even greater in terms of absolute weight of left ventricle infarcted (3.9 -66.5 g). SER varied inversely as infarct size ( fig. 2 ) (SER = -0.08514 (%LV) + 0.345, r = 0.98).
A similar range of infarct size was produced in embolization dogs (3.4 -42.2% of left ventricle, or 3.98 -62.5 g) (table IB) . There was no significant relationship of serum entry ratio to infarct size in the embolization dogs ( fig. 2 ).
The mean infarct size was not significantly different in ligation dogs (19.9% left ventricle ± 10.3, mean ± SD) vs embolization dogs (18.4% left ventricle ± 13.1) (table IA and 1B). The Kd for CPK did not differ significantly between ligation dogs (-0.00178 min-' 0.00049, mean ± SD) and embolization dogs (-0.00195 min-' ± 0.00053) (tables IA and B). Mean CPKr(Lv) ( 11. CPKr =%LV X 152 X 103 (-0.8514 %LV + 0.345) Therefore, for every infarct size, anticipated CPKr may be calculated and plotted as a function of %LV infarction ( fig. 3 ).
In figure 3 the actual values of CPKr measured in ligation dogs (normalized for LV/BW = 4.99) are plotted against the %LV infarction (determined from myocardial homogenization) and may be compared to the theoretical curve. Agreement is generally close, except for dog 6. If SER were a constant whatever infarct size, then CPKr would vary linearly with infarct size an assumption which has been made previously ( fig. 4A ). However, if there were an inverse linear relationship of SER to infarct size, then a given increment of in-INFARCT SIZE (%LV) farct size would produce a lesser increment of CPKr ( fig. 4B ). If the inverse relationship were sufficiently steep, as in the present study, the expected curve would be that of figure 3 (duplicated fig. 4C ). For each CPKr there are two infarct sizes lying within the range 1149 VOL 58, No 6, DECEMBER 1978 C;- therefore, CPKr increases linearly as infarct size increases. B) SER is inversely related to infarct size; therefore, each increment of infarct size produces a progressively smaller increment of CPKr. Within the range of infarct sizes at which survival is possible, CPKr continues to increase. C) SER vs infarct size relationship is steeper (SER = -0.8514 (%LV) + 0.345), as in the present study. CPKr rises as infarct size increases to 20.3% of left ventricle, then begins to fall as infarct size increases further. For each CPKr there are two possible infarct sizes within the range at which survival is possible. 10 20 30 40 50 IS (%LV) of infarct sizes at which survival is possible. In fact, in the situation illustrated in figure 4B , there would also be two infarct sizes calculated for each CPKr, but the larger value would be an infarct size at which survival is impossible and therefore only one real solution would emerge. In a noninvasive study to determine infarct size as %LV from CPKr, knowledge of LV weight and BW would permit calculation of infarct size by solution of a quadratic equation of the form: 12. a(%LV)2 + b(%LV) + CPKr = 0 (derived from 10 and 11 above) Figure 3 is the plot of this equation when LV/BW = 4.99 g/kg. Thus, when infarct size is calculated from CPKr for each ligation dog using this formula, two values are derived (table 3) . The value agreeing most closely with that measured from myocardial CPK assays, and most consistent with the clinical course was plotted against the measured value (ISc = 0.931 ISA -0.772, r = 0.93) ( fig. 5 ).
Discussion
It has been noted since the initial work of Shell et al. that during the course of acute myocardial infarction in dogs, the ratio of the amount of CPK entering the serum compared to the amount of CPK depleted from the myocardium (SER) was rather low. The value was initially reported as 0.3 0.02.1 This figure was subsequently modified to 0.15.2 It has been shown that cardiac lymphatics are the major escape route of myocardial enzymes to the distribution space.9' 10 It has been further shown that Kd of CPK in lymphatic fluid is very high," and that occluding cardiac lymphatic drainage results in lower fractional escape (SER) of CPK to the plasma.'2 It would be reasonable to postulate that prolonged contact of CPK with cardiac lymph during slow transport from the center of a large zone of homogeneous infarction might lead to extensive local destruction. SER would then be low. Conversely, more rapid lymphatic transit over shorter distances from the center of a small infarct would result in relatively less local destruction and therefore a higher SER. Such mechanisms may account for the inverse ratio of SER to infarct size observed in the ligation dogs in the present study.
The initial studies of Shell and Sobel demonstrated a linear correlation of peripheral CPK evolution and myocardial CPK depletion. ' Deviation of the actual from the theoretical curve of CPKr vs infarct size may be explained by variation 0 / about the linear fit of SER vs percent left ventricular infarction (r = 0.98), and by variations of normal myocardial CPK content, myocardial depletion ratio, and PV to body weight ratio. However, the pattern of rising CPKr to some maximum with a fall as infarct size increases is clear. Explanation of this phenomenon may be possible by modelling the system using multiple compartments to represent the processes of myocardial infarction, CPK exit from cells, CPK diffusion through interstitial spaces, CPK denaturation by lymphatic fluid and CPK mass transit 0/ by myocardial blood flow. against infarct size as %L V depletion deter-artery was ligated rather than the LAD, infarct size myocardial CPK assay. ISc = 0.931 ISA -estimate was based on myocardial histology rather 3. A bbreviations: ISc = calculated infarct size; than CPK depletion, the range of infarct size was ' infarct size; %L V = % left ventricle infarcted; 0.1-26.6 g rather than 6-45 CPK gram equivalents, iulative serum CPK. and finally, the estimate was made 5-6 days postinfarct vs 24 hours. The present study, using LAD ligation, infarct size estimation from myocardial CPK this data from the published figures and depletion, infarct range from 3.9 to 66.5 CPK gram at a correlation coefficient of 0.8244 to equivalents, and estimation at 48 hours postinfarct en infarct size estimated from peripheral onset is analogous in design to the Shell study, yet the id infarct size estimated from myocardial relationships of CPKr to infarct size are similar to on.'3 In their own experiments, however, those in the Roe study. iistological infarct size (HIS) to EE
The embolization experiments resulted in widely CPK was not directly measured), they scattered infarcts of varying size throughout the to find a correlation using total CPK and myocardium. A given infarct size in such an experirarct size from small to large.4 When they ment is the sum of many smaller infarcts, and ly small infarcts, there was a relationship therefore one would anticipate more rapid transit of E. However, with the larger infarcts EE the CPK from the central zones of infarction than Ias HIS increased.
would be observed from a single homogeneous infarc-3nt study assessed infarct size from tion of the same total size. The mean SER in em-CPK depletion rather than from bolized dogs was found to be significantly greater than owever the same phenomenon of falling in ligation dogs, supporting this reasoning. Further tus to CPKr in the present study) with support is provided by the finding of more rapid comsizes was observed. Thus, if theoretical pletion of infarction as determined from the time to erum CPK (CPKr) is plotted against in-reach the plateau of this cumulative CPK curve for percentage of left ventricle ( fig. 3 ) then it embolization dogs. hat CPKr rises as infarct size increases to
The SERs for embolization infarcts do not show the of about 20% of left ventricle. Beyond this same inverse linear relationship to infarct size as in the CPKr actually begins to fall. Therefore, ligation experiments. The distribution of micro-PKr value could arise from an infarct or spheres is random, and they may clump and produce ctly different sizes. When the actual ex-several large homogeneous areas of infarction in some ,sults are normalized for variations in left dogs and more scattered, small infarcts in other dogs. veight to body weight ratio, the CPKr
The distribution pattern of infarcts varies for a given seen to follow this pattern of peak CPK total infarct size from one dog to another, and an infarct size of 20-30% of left ventricle therefore, one might not anticipate a close relationship quent falling off of CPKr values ( fig. 3 ).
of SER to infarct size. --s z VOL 58, No 6, DECEMBER 1978 The mean Kd for CPK was 0.00187 min-' + 0.00051 (mean ± SD) (ligation and embolization dogs were not significantly different). Shell and Sobel noted an in vivo Kd of 0.0045 min-' ± 0.0010 for injected partially purified dog myocardial CPK.14 We found a closely similar value of 0.0047 min-' ± 0.0009.3 Thus, the Kd of endogenous CPK is markedly lower than that of exogenous CPK. This phenomenon was first noted by Sobel and Shell' and has been further commented upon by Roberts"5 and by Roe.4 The use of the individual Kd values assumes that f(t) = 0, whereas one cannot be certain of this in the present study. However, the straight-line fit of the data throughout the CPK decay curve is so close, that if some slow ongoing release of CPK were occurring, it is likely to be very small in relation to total CPKr. Additional explanations must be sought for the disparity between the Kds of endogenous and exogenous CPK. It may be that the injected CPK preparations are less stable than endogenous CPK.4 The 25% SD observed for injected CPK, and the marked difference from endogenous Kds, makes the use of a fixed mean Kd less desirable. We are using individually calculated Kds as advocated by Norris,'6 but recognize the potential limitations.
Roberts demonstrated a 50% reduction of Kd over the 3 hours after I.V. injection of pentobarbital 30 mg/kg.'7 The half-life of pentobarbital in dogs is only about 3.5 hours,'8 however, and reduction of Kd may therefore be of relatively short duration in relation to the total time of CPK release from the heart, which generally did not begin until 2.5 hours after ligation or embolization. However, the Kd calculated from the terminal portion of the exponential downslope of the serial CPK curve might be higher than the actual Kd at the time of pentobarbital action, and to the extent that this disparity exists, CPK entry into serum would be overestimated. Whatever the influence of the pentobarbital on Kd, it would be identical in the ligation and the embolization dogs, since each was anesthetized immediately before induction of myocardial infarction.
Roe and Starmer5 have emphasized the errors which may occur in the calculation of infarct size because of the variability of Kd, distribution volume (DV), CPKD (CPK depletion from infarcted zones), and Kr (fractional entry of CPK to serum or SER or PCPK). Variability of Kd in the present study emphasizes the necessity to determine this parameter in each dog.3 '7 DV has been shown to be equal to PV31,7 which may be estimated from body weight.8 Consideration should be given to determination of PV during infarct size studies. Variability of CPKD is a function of the variability of normal myocardial CPK content and of the CPK depletion in infarcted zones. The CPKD cannot be estimated noninvasively. In dog ligation experiments, the SER varies inversely with infarct size. Therefore, the measured CPKr could be used to solve a quadratic equation yielding two values for infarct size (left ventricular weight would have to be estimated noninvasively). The clinical and hemodynamic course of the animal should generally permit selection of the appropriate infarct size. Such an ap-proach gives rise to a relatively close relationship between infarct size determined from myocardial CPK depletion and infarct size calculated from CPKr (r = 0.93) ( fig. 4 ).
The cautions advised by Roe et al.4 5 are warranted. However, their interpretation of the serial CPK data led them to conclude that the serial CPK technique did not distinguish large from small infarcts. 4 The findings in the present study indicate that although large infarcts may give rise to cumulative serum CPK entry values no different from certain small infarcts, there is a predictable variation of CPK serum entry with infarct size, permitting calculation of correct infarct size from serial CPK data when the infarct is produced by coronary artery ligation.
The SER is unpredictable in the embolization experiments in the present study, and would also be unpredictable in reperfusion experiments because of washout of CPK. 19 20 In humans, to the extent that spontaneous myocardial infarction may be considered analogous to ligation experiments, corrections might be made for variation of SER with infarct size. However, the correlation of rising CPKr with worsening prognosis already reported in the literature'6-24 suggest that the phenomenon of decreasing values of CPKr with larger infarction may not be observed in humans. It is possible that the peak of the CPKr vs infarct size curve in humans occurs at infarct sizes at which survival is impossible, so that in patients who survive, infarct size has only a single value for each CPKr (fig. 4B ). On the other hand, human infarction may not be analogous to simple ligation. There is considerable data indicating that coronary artery thrombus may not underlie many infarctions,25 and therefore the kinetics of CPK release may be different from those in the dog ligation model.
A further problem in humans might arise because some myocardial infarctions, though small, may be diffuse and non-homogeneous,26 a situation analogous to the embolization experiments. Large SERs might occur and might account for the observation by us (unpublished data) and others23 in some patients of high CPKr in the absence of power failure. Selection of an appropriate SER for infarct size calculation would not be possible in such a case. Aggregated platelets may be a factor in the causing of human infarction. There is experimental27 and human autopsy28 evidence that platelets may produce scattered myocardial infarction. Such a mechanism of infarction may be simulated by the microsphere embolization model. Jarmakani et al.'7 have considered the possible effects on CPK release of varying degrees of reperfusion in human infarction. Unpredictable changes in degree of coronary occlusion or establishment of collateral flow could produce variation of SER, distorting infarct size calculations.
The findings of our study have major implications for the calculation of infarct size in dogs and in man. We need to individualize, whenever possible, the various parameters of the infarct size equation. The great variation of SER with infarct size and model 1152 CIRCULATION necessitates more complex calculations for determination of infarct size and indicates that in some settings, meaningful quantitation may not be possible with this technique. The assumption that human infarction is analogous to coronary ligation infarction of the dog must be examined carefully.
